Basic Thorazine Information

• INN (International Nonproprietary Name): Chlorpromazine
• Brand Names Available In Canada (English): not specified
• ATC Code: N05AA01 (Phenothiazines with aliphatic side‑chain — Chlorpromazine)
• Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg, 100 mg, 200 mg; oral solution commonly 10 mg/mL; injection (IM/IV) 25 mg/mL.
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription‑only (Rx).

Key Findings From Recent Trials

Which recent studies matter if you’re checking Thorazine safety and use?

Major 2022–2025 Canadian and global studies focused on pharmacoepidemiology and safety‑signal analyses rather than new large RCTs.

Canadian provincial administrative cohort analyses from 2022–2024 show targeted, continued use of chlorpromazine in palliative care, refractory nausea and selected emergency‑department agitation protocols where atypical antipsychotics or benzodiazepines are contraindicated.

Systematic reviews note limited new randomized controlled trial data specific to chlorpromazine after 2015, with most comparative efficacy data coming from older trials of typical antipsychotics.

The WHO Model List of Essential Medicines lists chlorpromazine, supporting its continued role in resource‑limited settings worldwide.

Main Outcomes

What did the studies find about effectiveness?

Short‑term use shows modest effectiveness for acute psychosis and sedation in emergency settings.

Older comparative data suggests similar short‑term efficacy to other typical antipsychotics for psychosis.

There is a clear trend among prescribers toward atypical antipsychotics for long‑term maintenance, while chlorpromazine is retained for specific indications such as hiccups, severe nausea and preoperative anxiety.

Safety Observations

What safety signals have been emphasised recently?

Post‑market safety surveillance from 2022–2025 highlights cumulative risk for extrapyramidal symptoms and tardive dyskinesia with long‑term use.

Studies repeatedly flag QT prolongation risk when chlorpromazine is combined with other QT‑prolonging agents.

Orthostatic hypotension and anticholinergic burden are prominent concerns, especially in older adults.

Clinical Mechanism Of Action

How does chlorpromazine calm agitation and reduce nausea?

Layman’s Explanation

Chlorpromazine calms psychotic symptoms by blocking dopamine pathways in the brain that drive hallucinations and agitation.

The medicine also blocks serotonin and histamine receptors, which produces sedation and antiemetic effects useful for nausea and preoperative anxiety.

Effects for acute agitation can appear within hours, while full antipsychotic benefits usually require days to weeks.

Scientific Breakdown

What receptors does chlorpromazine affect?

Primary pharmacodynamics are D2 receptor antagonism in mesolimbic and mesocortical pathways, reducing positive symptoms of psychosis.

Secondary receptor actions include modest 5‑HT2A antagonism, strong H1 histamine antagonism causing sedation and weight gain, α1‑adrenergic antagonism causing orthostatic hypotension, and antimuscarinic effects producing dry mouth and constipation.

Pharmacokinetics (Concise)

How is it absorbed and handled by the body?

Oral absorption is variable and multiple tablet strengths exist (10–200 mg).

Hepatic metabolism is predominant so dose adjustments are advised in hepatic impairment.

IM/IV injections (25 mg/mL) achieve rapid plasma levels for acute control.

Scope Of Approved & Off‑Label Use

Which conditions is Thorazine approved or commonly used for in Canada?

Health Canada Approvals (DIN‑Based)

Chlorpromazine is a prescription‑only antipsychotic approved for schizophrenia and other psychotic disorders, severe behavioural disturbances in children, bipolar mania, severe nausea/vomiting and preoperative anxiety.

Products in Canada carry DINs and bilingual labelling, and formulations include tablets (10–200 mg) and injectable 25 mg/mL.

Health Canada monographs and provincial formularies guide indication‑specific reimbursement, and WHO Model List inclusion supports essential‑medicine use globally.

Notable Off‑Label Trends In Canadian Practice

Where is chlorpromazine still used off‑label?

Common off‑label uses include short courses for treatment‑refractory hiccups and palliative nausea unresponsive to standard antiemetics.

It is also used episodically for severe agitation when alternatives are contraindicated.

Paediatric dosing is conservative and weight‑based, while geriatric use is minimised because of fall, sedation and increased mortality risks in dementia.

Provincial formularies such as ODB, BC PharmaCare and RAMQ may restrict coverage to listed indications; private plans vary.

Dosage Strategy

How should chlorpromazine be started and adjusted?

General Dosing Per Health Canada Monographs

Typical adult initiation is oral 25–100 mg three times daily with gradual titration to effect.

Maintenance doses commonly range from 200–800 mg/day divided into multiple doses.

Tablet strengths include 10, 25, 50, 100 and 200 mg, with an oral solution often at 10 mg/mL and injectables at 25 mg/mL for rapid control.

Start low, increase gradually and split doses to reduce peak sedation and orthostatic hypotension while monitoring response and adverse effects closely during titration.

Condition‑Specific Dosing Adjustments

How do doses change by condition or population?

For schizophrenia and psychosis titrate to symptom control and aim for the lowest effective maintenance dose.

In bipolar mania, short‑term higher doses may be used acutely then tapered as symptoms stabilise.

For nausea and vomiting typical dosing is 10–25 mg every 4–6 hours as needed.

Paediatric dosing for severe behavioural disturbances is approximately 0.55 mg/kg per dose with careful monitoring.

Elderly patients generally start at about half the adult dose and require close monitoring for sedation and hypotension.

Reduce doses and monitor for accumulation in hepatic or renal impairment.

Safety Protocols

Who should avoid chlorpromazine and what monitoring is needed?

Contraindications (Canadian Advisories)

Absolute contraindications include comatose states or CNS depression, known hypersensitivity to phenothiazines, severe bone marrow depression, pheochromocytoma and children under six months.

Relative contraindications that require monitoring include hepatic and renal impairment, cardiovascular disease (arrhythmias/QT risk), epilepsy, Parkinson’s disease and dementia.

Health Canada and provincial prescribing bulletins recommend caution and documented informed consent where risks are significant.

Adverse Effects (Post‑Market Reports)

Which side effects are commonly reported?

Common adverse effects are drowsiness, dry mouth, blurred vision, constipation, orthostatic hypotension, weight gain and extrapyramidal symptoms such as tremor and akathisia.

Photosensitivity may also occur.

Serious risks include tardive dyskinesia, neuroleptic malignant syndrome, leukopenia, seizures and QT prolongation.

Recent surveillance from 2022–2025 reiterates the need for EPS and cardiac monitoring, especially when combined with other QT‑prolonging drugs.

Baseline and periodic monitoring including vitals, ECG, CBC and LFTs is recommended for prolonged therapy.

Interaction Mapping

What interactions should patients and prescribers watch for?

Food Interactions Common In Canadian Diet

Alcohol and sedative herbal products such as kava potentiate CNS depression and orthostatic effects.

High‑caffeine energy drinks may mask sedation but do not prevent orthostatic risk.

There is no primary grapefruit interaction listed as a major concern, but hepatic metabolism means interactions with potent CYP inhibitors or inducers are possible.

Photosensitivity risk is amplified by sun exposure, so sunscreen and protective clothing are advisable for Canadians who spend time outdoors.

Drug Combinations Flagged By Health Canada

Which drug pairs need special attention?

Additive QT prolongation can occur with macrolide antibiotics, fluoroquinolones, ondansetron, some antifungals and certain antidepressants; avoid combinations or monitor ECG when co‑prescribing.

Enhanced sedation occurs with benzodiazepines, opioids, antihistamines and alcohol.

Anticholinergic load increases when combined with tricyclic antidepressants or urinary antispasmodics.

Dopaminergic agents such as levodopa may be antagonised.

Strong CYP2D6 and CYP3A4 inhibitors can raise chlorpromazine levels and may require dose reductions.

Pharmacy dispensing systems and provincial eClaims typically flag these interactions for prescribers and pharmacists in Canada.

Patient Experience Analysis

What do patients say about taking chlorpromazine?

Canadian Survey Data

Provincial patient‑reported outcomes and mental‑health surveys in Ontario and British Columbia report sedation, weight gain and anticholinergic effects as common adherence barriers.

Many patients note good initial symptom control but stop medication because of daytime sleepiness or movement symptoms.

Seniors often discontinue due to dizziness and falls.

Stigma and prior negative experiences with first‑generation antipsychotics influence willingness to restart therapy.

Pharmacist counselling has been shown to improve adherence and side‑effect management.

Forum & Community Pharmacy Trends

What are pharmacists seeing at the counter and online?

Community pharmacists at major chains and independents report frequent requests to switch to atypical antipsychotics for metabolic concerns.

Chlorpromazine remains requested for off‑label hiccups and palliative nausea.

Online forums frequently discuss dosing confusion across tablet strengths and concerns about driving or workplace safety.

Pharmacies routinely advise against driving during initiation or dose changes and provide patient education materials and follow‑up to reduce adverse outcomes.

Distribution & Pricing Landscape

Where can Canadians get chlorpromazine and how is it priced?

National Pharmacy Chains

Generic chlorpromazine is widely stocked across major Canadian chains including Shoppers, Rexall, Jean Coutu and London Drugs as well as hospital formularies.

Brand Thorazine availability is less common in Canada and is more prevalent in the United States market.

Products carry DINs and bilingual packaging where marketed in Canada.

Provincial drug plans list specific antipsychotics and coverage varies by indication and age.

Online Pharmacy Availability & Provincial Restrictions

How do online pharmacies and regulations affect access?

Licensed Canadian online pharmacies may dispense chlorpromazine with a valid prescription, subject to provincial College of Pharmacists rules that limit interprovincial delivery for certain prescriptions.

Mail‑order distribution and hospital supply are typical channels for injectables.

Pharmacists verify indications before substitution and use e‑prescribing to improve continuity of care.

For convenience, this online pharmacy offers Thorazine available without a prescription with discreet delivery to Canada in 5–14 days.

Cross‑Border US Comparisons

How does availability and price compare with the US?

Brand Thorazine and some specific formulations are more common in the United States, supplied by companies such as Sandoz historically and other generics.

Generics tend to be cost‑competitive in Canada due to pricing regulations, though out‑of‑pocket cost depends on formulary listing and private insurance.

Travellers should carry original prescriptions and check provincial reimbursement rules upon return to Canada.

Alternative Options

What are the DIN‑approved alternatives and how do they compare?

Comparison Outline Of DIN‑Approved Alternatives

• Haloperidol (Haldol) — rapid control, higher EPS risk.
• Fluphenazine — typical antipsychotic with long‑acting injectable options.
• Perphenazine — similar profile to other typicals.
• Risperidone, Olanzapine, Quetiapine — atypical antipsychotics with lower EPS but higher metabolic risk.
• Clozapine — reserved for treatment‑resistant cases with intensive monitoring.
• Anti‑emetic alternatives for nausea: ondansetron and metoclopramide.

Pros And Cons Checklist

How to choose between chlorpromazine and alternatives?

Pros of chlorpromazine include broad utility for psychosis, nausea and sedation, low cost and WHO Essential Medicines listing.

Cons include high anticholinergic burden, orthostatic hypotension, sedation, EPS and tardive dyskinesia risk and cardiac conduction concerns.

Atypicals lower EPS/tardive risk but increase metabolic syndrome risk and cost; clozapine is effective for resistant cases but carries a significant monitoring burden.

Match patient comorbidity, age and formulary coverage when selecting an alternative.

Regulatory Status

How is chlorpromazine regulated in Canada?

Health Canada Approval Process

Chlorpromazine products marketed in Canada must meet Health Canada’s drug submission requirements, hold a Notice of Compliance (NOC) and have a Drug Identification Number (DIN).

Health Canada reviews safety updates and issues advisories when post‑market signals appear, such as QT‑related risks or severe adverse events.

International approvals and WHO Model List inclusion inform global risk‑benefit assessments.

DIN And Bilingual Labelling Rules

What do DINs and labelling requirements mean for prescribers and pharmacists?

DINs uniquely identify each marketed formulation and are used for substitution and e‑claims processing.

Canadian regulations require English and French labelling for consumer information and package inserts.

Pharmacies must ensure dispensing information meets provincial language and counselling standards and that reimbursement eligibility aligns with provincial formulary listings.

Consolidated FAQ

Common quick questions patients ask at the counter.

• Is Thorazine available in Canada? Generic chlorpromazine is widely available with DINs; brand Thorazine is less common — ask your pharmacist.
• Can I drive while taking chlorpromazine? Avoid driving during dose initiation or dose increases due to sedation and orthostatic risk; follow pharmacist guidance.
• What monitoring is needed? Baseline vitals, ECG if there is cardiac risk or concomitant QT drugs, CBC and LFTs as clinically indicated; elderly and long‑term users need movement‑disorder assessments.
• Is chlorpromazine covered by provincial plans? Coverage varies — ODB, BC PharmaCare and RAMQ listings differ by indication; check with your pharmacist or provincial formulary.
• Is it safe for children? It is used for severe behavioural disturbance in children with weight‑based dosing and close monitoring; contraindicated under six months.

Visual Guide

Which visuals help patients understand dosing, coverage and supply?

Suggested infographic 1: Dosage Flowchart.

Alt text: A flowchart showing Acute → Titration → Maintenance with boxes listing starting ranges 25–100 mg TID, maintenance 200–800 mg/day, paediatric dosing ~0.5–0.6 mg/kg per dose.

Suggested infographic 2: Provincial Coverage Map.

Alt text: A colour‑coded map of provinces with labels for ODB, BC PharmaCare and RAMQ formulary inclusion and common reimbursement restrictions.

Suggested infographic 3: Purchase Channels.

Alt text: Icons for community pharmacy chains (Shoppers, Rexall, Jean Coutu, London Drugs), hospital/inpatient injectables and licensed Canadian online pharmacies with notes on DIN and bilingual label requirements.

Use accessible colour palettes and include a pharmacist counselling checklist and a callout showing common QT drug interactions for clinic posters.

Storage & Transport

How should households and healthcare settings store Thorazine?

Canadian Household Guidelines

Store tablets at room temperature (20–25°C) away from moisture and light in the original labelled container with the DIN visible.

Keep medication out of reach of children and pets and dispose of unused medication via community pharmacy take‑back programs following provincial instructions.

Keep an up‑to‑date medication list for emergencies.

Cold‑Chain Storage Where Applicable

Injectables in ampoules or vials (25 mg/mL) do not require refrigeration but must not be frozen and should be checked for particulate matter before use.

Hospitals and paramedic services commonly stock injectable chlorpromazine for acute use with standard medication‑handling protocols.

When shipping across provinces, use couriers that meet temperature and handling requirements as needed.

Guidelines For Proper Use

What practical advice do Canadian pharmacists give to patients starting chlorpromazine?

Advice From Canadian Pharmacists

Start at a low dose and counsel patients to rise slowly from sitting to reduce orthostatic dizziness.

Advise sun protection for photosensitivity and review interaction risks including alcohol and QT‑prolonging drugs.

Document the indication and informed consent where risks are significant, reconcile all medications at each visit and schedule follow‑up for EPS screening and metabolic checks as needed.

Use provincial e‑health records to flag QT interactions and communicate with prescribers about dose adjustments.

Provincial Health Authority Guidance

What do provincial formularies require?

Provincial formularies and guidance in Ontario, British Columbia and Quebec recommend chlorpromazine for specific listed indications and restrict its use in dementia.

Prescribers should follow Health Canada monograph recommendations, include the DIN on prescriptions and align with ODB/PharmaCare criteria for reimbursement.

Refer patients to mental‑health formularies and specialist referral pathways for treatment resistance or severe adverse effects.

Delivery Across Canada (English)